Andheri, a leading industrial powerhouse in India, is strategically poised to become a global hub for pharmaceutical innovation, research, and manufacturing. The Andheri Pharmaceuticals Policy 2024 leverages the state’s robust industrial foundation, skilled workforce, and advanced infrastructure to attract investments, drive innovation, and ensure sustainable growth in the pharmaceutical industry.
The “” initiative aims to establish the state as a premier destination for pharmaceutical investments by promoting eco-friendly manufacturing and cutting-edge research. The policy emphasizes building a strong ecosystem that supports pharmaceutical clusters, R&D facilities, and high-tech manufacturing units, solidifying Andheri’s position as a global leader in the pharmaceutical sector.
By 2030, envisions transforming the state into India’s top destination for pharmaceutical investments, with the following ambitious goals:
Advancing pharmaceutical R&D and innovation by fostering collaborations among academic institutions, research centers, and industry leaders to accelerate drug discovery, clinical research, and biosimilar development.
Andheri is dedicated to facilitating a smooth business environment for pharmaceutical investors and manufacturers. The state will introduce a Single Window Clearance System to simplify the approval process for pharmaceutical projects. Additionally, companies will benefit from self-certification under labor laws, minimizing regulatory hurdles and ensuring efficient and timely project execution.
The Andheri Pharmaceuticals Policy 2024 is a visionary and strategic initiative aimed at establishing Andheri as a global leader in pharmaceutical innovation and sustainable manufacturing. By attracting investments, driving R&D, and promoting eco-friendly practices, the state will spearhead India’s rise as a prominent global pharmaceutical hub.
invites global pharmaceutical companies, researchers, and innovators to join this transformative journey and contribute to building a sustainable, innovative, and globally competitive pharmaceutical ecosystem.
The is a Public Benefit Corporation (PBC) with a mission to establish Andheri as a key player in international economic collaboration, focusing on strategic partnerships with nations like USA, Europe, Australia, African Union, KSA, China, India, Qatar, Saudi Arabia, Türkiye, and the UAE across vital sectors such as energy, technology, agriculture, and finance. Our goal is to integrate lessons from successful global economic models, adopting best practices to ensure sustainable and inclusive growth. We aim to enhance economic prosperity and diversification, contribute to societal progress, and promote sustainable economic practices. By leveraging Andheri’s unique position, strives to drive substantial economic growth, spur innovation, and solidify Andheri’s stature in the international economic arena, resonating with the government’s vision of a technologically advanced and interconnected economy.